These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 26950376)
1. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Varma A; Saliba RM; Torres HA; Afrough A; Hosing C; Khouri IF; Nieto Y; Shah ND; Parmar S; Bashir Q; Ahmed S; Jones RB; Kebriaei P; Olson AL; Shpall EJ; Alousi AM; Qazilbash MH; Champlin RE; Popat U Bone Marrow Transplant; 2016 Jul; 51(7):999-1001. PubMed ID: 26950376 [No Abstract] [Full Text] [Related]
2. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Kyvernitakis A; Mahale P; Popat UR; Jiang Y; Hosry J; Champlin RE; Torres HA Biol Blood Marrow Transplant; 2016 Apr; 22(4):717-722. PubMed ID: 26712592 [TBL] [Abstract][Full Text] [Related]
3. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT). Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M Front Immunol; 2018; 9():2153. PubMed ID: 30294330 [TBL] [Abstract][Full Text] [Related]
4. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma. Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522 [TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents. Mizuno S; Takami A; Takamatsu H; Hanamura I; Shimazu Y; Hangaishi A; Tsukada N; Kako S; Kikuchi T; Ota S; Shimizu H; Iida S; Yoshioka S; Sawa M; Fukuda T; Kanda Y; Atsuta Y; Kawamura K Bone Marrow Transplant; 2022 May; 57(5):846-848. PubMed ID: 35332303 [No Abstract] [Full Text] [Related]
6. Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma. Adam M; Benbunan M; Fermand JP; Gisselbrecht C; Sitthy X; Maréchal B; Marchix T; Gerota J Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():33-4. PubMed ID: 1969307 [No Abstract] [Full Text] [Related]
7. Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). Kato H; Kato K; Kim SW; Fukuda T; Mori T; Sawa M; Ohno Y; Yoshioka S; Iwato Y; Taji H; Onizuka M; Kurahashi S; Ichinohe T; Suzumiya J; Suzuki R Br J Haematol; 2019 Sep; 186(6):e170-e175. PubMed ID: 31206602 [No Abstract] [Full Text] [Related]
8. Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan. Tsukune Y; Sasaki M; Odajima T; Sunami K; Takei T; Moriuchi Y; Iino M; Isoda A; Nakaya A; Muta T; Miyake T; Miyazaki K; Shimizu T; Nakajima K; Igarashi A; Nagafuji K; Kurihara T; Aoyama T; Sugimori H; Komatsu N Blood Cancer J; 2017 Nov; 7(12):631. PubMed ID: 29167420 [No Abstract] [Full Text] [Related]